They are entering a new era of medicine
A T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors.
Address:
San Francisco - United States of America
Contact:
contact@lyell.com
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.
